XML 65 R53.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value Measurements (Schedule Of Fair Value Hierarchy, Assets (Liabilities) Carried At Fair Value) (Details) - USD ($)
$ in Thousands
9 Months Ended
Oct. 03, 2016
Feb. 10, 2016
Jan. 19, 2016
Mar. 31, 2017
Mar. 31, 2016
Jun. 30, 2016
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
business combination, contingent consideration arrangement, payment       $ 0 $ (9,900)  
Payments to Acquire Businesses, Net of Cash Acquired       184,600 67,300  
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value       15,900   $ 5,200
Long-term Debt, Fair Value       $ 97,000    
Fair Value Inputs, Discount Rate       1.00%    
Interest Rate Derivative Instruments       $ 900   (1,300)
Foreign Currency Fair Value Hedge Derivative at Fair Value, Net       800   (5,300)
Business Acquisition, Contingent Consideration, at Fair Value       (15,900)   (5,200)
Business Combination, Expected Contingent Consideration Payment       (15,900)    
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings       800 $ (8,200)  
Liabilities, Fair Value Disclosure, Recurring       (14,200)   (11,800)
Fair Value, Inputs, Level 1 [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Interest Rate Derivative Instruments       0   0
Foreign Currency Fair Value Hedge Derivative at Fair Value, Net       0   0
Business Acquisition, Contingent Consideration, at Fair Value       0   0
Total       0   0
Fair Value, Inputs, Level 2 [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Interest Rate Derivative Instruments       900   (1,300)
Foreign Currency Fair Value Hedge Derivative at Fair Value, Net       800   (5,300)
Business Acquisition, Contingent Consideration, at Fair Value       0   0
Liabilities, Fair Value Disclosure, Recurring       1,700   (6,600)
Fair Value, Inputs, Level 3 [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Interest Rate Derivative Instruments       0   0
Foreign Currency Fair Value Hedge Derivative at Fair Value, Net       0   0
Business Acquisition, Contingent Consideration, at Fair Value       (3,300)   (5,200)
Business Combination, Expected Contingent Consideration Payment       15,900    
Liabilities, Fair Value Disclosure, Recurring       (15,900)   (5,200)
ClinIntel Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Business Acquisition, Contingent Consideration, at Fair Value       $ (8,200)    
Health Advances Acquisition [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Business Combination, Consideration Transferred   $ 71,600        
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High     $ 15,800      
Payments to Acquire Businesses, Net of Cash Acquired   67,100 $ 67,100      
Fair Value Inputs, Discount Rate       1.00%    
Business Acquisition, Contingent Consideration, at Fair Value       $ (4,500)    
Health Advances Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Business Acquisition, Contingent Consideration, at Fair Value       $ (1,900)    
ExecuPharm Inc. [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Business Combination, Consideration Transferred   $ 167,200        
Payments to Acquire Businesses, Gross $ 148,900          
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High 20,000          
Payments to Acquire Businesses, Net of Cash Acquired 148,500          
Fair Value Inputs, Discount Rate       1.00%    
Business Acquisition, Contingent Consideration, at Fair Value $ (9,400)     $ (11,900)    
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings       (2,500)    
Forward Contracts [Member]            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value       0   $ 0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings       20,700    
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Issuances       $ (19,300)